Skip to Content
  • Previous Rank250
  • Revenues ($M)24,890
  • Revenue Percent Change122.2%
  • Profits ($M)12,101
  • Profits Percent Change293.6%
  • Market Value (as of March 31, 2015)145,533

The biopharmaceutical company develops medications that are used to treat patients with HIV/AIDS, hepatitis, and cardiovascular disease, among others.

Fortune Data StoreLooking for leads, investment insights, or competitive intelligence?Get Premium Access

Company Info

CEO
John F. Milligan
Industry
Pharmaceuticals
Sector
Health Care
HQ Location
Foster City, CA
Websitehttp://www.gilead.com
Years on List7

Key Financials (last fiscal year)

$ millions% change
Revenues ($M)24,890122.2%
Profits ($M)12,101293.6%
Total Stockholder Equity15,426-
Employees7,000-
Market Value (as of March 31, 2015)145,533-

Profit Ratios

Profit as % of Revenues48.6%
Profits as % of Assets34.9%
Profits as % of Stockholder Equity78.4%

Earnings Per Share (last fiscal year)

Earnings Per Share ($)7.35
EPS % Change (from 2013)306.1%
EPS % Change (5 year annual rate)39.1%
EPS % Change (10 year annual rate)40.4%

Total Return

Total Return to Investors (2014)25.5%
Total Return to Investors (5 year, annualized)34.2%
Total Return to Investors (10 year, annualized)26.8%